GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nexien Biopharma NXEN · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 2 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Nexien Biopharma — daily NXEN Delayed
Market value
$7,077
Last close × shares
Volume
100
Shares, 2 Nov 2026

About Nexien Biopharma

Its shares trade under the ticker NXEN. It has been listed since 11 July 2001.

Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. The company is headquartered in Glendale, Colorado. The company went IPO on 2001-07-11. The firm is engaged in the business of developing drugs containing cannabinoids or terpenes, for the treatment of various diseases, disorders and medical conditions.

Figures and description from our data supplier, not checked against the company's own report.

More about Nexien Biopharma →

Latest on Nexien Biopharma

Our reporting

We have not reported on Nexien Biopharma yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Nexien Biopharma's ticker?

Nexien Biopharma trades as NXEN on its US listing, under ISIN US65343D1000.

What was Nexien Biopharma's last closing price?

0.00 on 2 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.